BB Biotech AG total revenue, net income and dynamics of changes in Euro today
BB Biotech AG revenue for the past few reporting periods. Net revenue BB Biotech AG is now 144 258 000 €. Information about net revenue is taken from open sources. Net income of BB Biotech AG today amounted to 128 547 000 €. The financial report on the chart of BB Biotech AG allows you to clearly see the dynamics of fixed assets. The value of "net income" BB Biotech AG on the graph is displayed in blue. BB Biotech AG total revenue on the graph is shown in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
147 508 903.65 €
-
131 443 850.86 €
-
31/03/2021
240 863 312.95 €
-59.308 % ↓
225 927 139.18 €
-75.168 % ↓
31/12/2020
695 127 707.12 €
-
679 663 905.11 €
-
30/09/2020
0 €
-100 % ↓
-404 123 351.04 €
-
30/09/2019
209 619.75 €
-
-390 369 228.13 €
-
30/06/2019
-378 283 882.90 €
-
-343 372 481.18 €
-
31/03/2019
591 910 944.42 €
-
909 832 520.90 €
-
31/12/2018
-208 233 187.59 €
-
-657 339 913.48 €
-
Show:
to
BB Biotech AG financial report charts
Dates of BB Biotech AG finance reports: 31/12/2018, 31/03/2021, 30/06/2021. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of BB Biotech AG for today is 30/06/2021. Gross profit BB Biotech AG is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit BB Biotech AG is 144 258 000 €
BB Biotech AG quarterly report dates
Total revenue BB Biotech AG refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue BB Biotech AG is 144 258 000 € Operating income BB Biotech AG is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income BB Biotech AG is 129 601 000 € Net income BB Biotech AG is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income BB Biotech AG is 128 547 000 €
Current assets BB Biotech AG is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets BB Biotech AG is 4 357 070 000 € Total assets BB Biotech AG refers to the total amount of assets owned by a person or entity. Total assets BB Biotech AG is 4 357 070 000 € Current cash BB Biotech AG - the sum of all of the cash a company has on the date of report. Current cash BB Biotech AG is 3 174 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
147 508 903.65 €
240 863 312.95 €
695 127 707.12 €
-
209 619.75 €
-378 283 882.90 €
591 910 944.42 €
-208 233 187.59 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
147 508 903.65 €
240 863 312.95 €
695 127 707.12 €
-
209 619.75 €
-378 283 882.90 €
591 910 944.42 €
-208 233 187.59 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
209 619.75 €
-378 283 882.90 €
591 910 944.42 €
-208 233 187.59 €
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
132 521 603.11 €
225 778 871.56 €
681 353 133.50 €
-12 045 466.35 €
-11 391 043.73 €
-390 419 332.36 €
579 218 213.20 €
-219 848 166.56 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
131 443 850.86 €
225 927 139.18 €
679 663 905.11 €
-404 123 351.04 €
-390 369 228.13 €
-343 372 481.18 €
909 832 520.90 €
-657 339 913.48 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
14 987 300.54 €
15 084 441.39 €
13 774 573.62 €
12 045 466.35 €
11 600 663.48 €
12 135 449.46 €
12 692 731.22 €
11 614 978.97 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
4 455 258 071.17 €
4 379 434 007.81 €
4 052 445 610.44 €
3 558 973 121.04 €
3 307 276 046.12 €
3 726 778 328.74 €
4 077 320 827.75 €
3 156 407 091.33 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
4 455 258 071.17 €
4 379 434 007.81 €
4 052 445 610.44 €
3 558 973 121.04 €
3 307 276 046.12 €
3 726 778 328.74 €
4 077 320 827.75 €
3 156 407 091.33 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
3 245 527.18 €
4 002 203.34 €
6 969 600.90 €
15 218 393.52 €
9 635 350.55 €
8 994 220.89 €
8 596 454.64 €
22 569 400.11 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
354 447 561.49 €
383 580 615.98 €
390 750 633.81 €
206 891 621.22 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
354 447 561.49 €
383 580 615.98 €
390 750 633.81 €
206 891 621.22 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
10.72 %
10.29 %
9.58 %
6.55 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
4 138 200 537.06 €
4 006 756 686.20 €
3 975 154 208.86 €
3 303 915 994.98 €
2 952 828 484.63 €
3 343 197 712.76 €
3 686 570 193.94 €
2 949 515 470.12 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
31 534 990.01 €
6 199 631.79 €
-35 118 976.39 €
156 079 794.90 €
Last revenue report of BB Biotech AG was 30/06/2021. According to last financial report total revenue in BB Biotech AG was 147 508 903.65 Euro and changed by -59.308% since last year. Net income in BB Biotech AG was 131 443 850.86 € in last quartal, net income changes to -75.168%.
BB Biotech AG stocks data
BBZA.DE stock price
BB Biotech AG stock price today, BBZA.DE stock quote.
